0001225208-20-007572.txt : 20200513 0001225208-20-007572.hdr.sgml : 20200513 20200513160930 ACCESSION NUMBER: 0001225208-20-007572 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200511 FILED AS OF DATE: 20200513 DATE AS OF CHANGE: 20200513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOBO DONALD E JR CENTRAL INDEX KEY: 0001196661 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 20873244 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2020-05-11 0001099800 Edwards Lifesciences Corp EW 0001196661 BOBO DONALD E JR ONE EDWARDS WAY IRVINE CA 92614 1 CVP,Strategy/Corp Development Common Stock 2020-05-11 4 M 0 6343.0000 0 A 28789.5169 D Common Stock 2020-05-11 4 F 0 685.0000 217.8400 D 28104.5169 D Common Stock 2020-05-11 4 F 0 3145.0000 217.8400 D 24959.5169 D Common Stock 2020-05-12 4 F 0 709.0000 225.0500 D 24250.5169 D Common Stock 12673.1148 I 401(k) Common Stock 176.0000 I By Son Common Stock 41232.0000 I By Trust Performance Rights 2020-05-11 4 M 0 6343.0000 0.0000 D 2020-05-11 Common Stock 6343.0000 0.0000 D On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form. Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2020-05-13